Distinguishing clinical characteristics of central nervous system tuberculosis in immunodeficient and non-immunodeficient individuals: a 12-year retrospective study

Central nervous system tuberculosis (CNS TB) is a severe Mycobacterium tuberculosis (MTB) infection. It is unclear whether a patient's immune status alters the clinical manifestations and treatment outcomes of CNS TB. Between January 2007-December 2018, chart reviews of CNS TB, including tuberc...

Full description

Saved in:
Bibliographic Details
Published in:Annals of clinical microbiology and antimicrobials 2023-08, Vol.22 (1), p.69-69, Article 69
Main Authors: Saifon, Woraseth, Karaketklang, Khemajira, Jitmuang, Anupop
Format: Article
Language:English
Subjects:
Abscess
Abscesses
Acids
Adult
Age
Blood cell count
Care and treatment
Central nervous system
Cerebrospinal fluid
Clinical outcomes
Complications and side effects
Demographic aspects
Diagnosis
Female
Health aspects
Hemoglobin
HIV
HIV Infections - complications
Human immunodeficiency virus
Humans
Immune status
Immunodeficiency
Infections
Leukocytes
Male
Meningitis
Middle Aged
Mortality
Multidrug resistance
Mycobacterium tuberculosis
Myelitis
Nervous system
Patients
Pulmonary tuberculosis
Radiography
Retrospective Studies
Sample size
Spinal cord
Tuberculoma
Tuberculoma - complications
Tuberculosis
Tuberculosis, Central Nervous System - complications
Tuberculosis, Central Nervous System - diagnosis
Tuberculosis, Central Nervous System - drug therapy
Tuberculosis, Meningeal - complications
Tuberculosis, Meningeal - diagnosis
Tuberculosis, Meningeal - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c564t-e7a160cc66c3748b05e9d8bb0b5dcbe10c5b5b2d74fbfee5fe4d89a3481811733
cites cdi_FETCH-LOGICAL-c564t-e7a160cc66c3748b05e9d8bb0b5dcbe10c5b5b2d74fbfee5fe4d89a3481811733
container_end_page 69
container_issue 1
container_start_page 69
container_title Annals of clinical microbiology and antimicrobials
container_volume 22
creator Saifon, Woraseth
Karaketklang, Khemajira
Jitmuang, Anupop
description Central nervous system tuberculosis (CNS TB) is a severe Mycobacterium tuberculosis (MTB) infection. It is unclear whether a patient's immune status alters the clinical manifestations and treatment outcomes of CNS TB. Between January 2007-December 2018, chart reviews of CNS TB, including tuberculous meningitis (TBM), tuberculoma/abscess, and TB myelitis, were made. Subjects were categorized as immunodeficient (ID) and non-immunodeficient (NID). Of 310 subjects, 160 (51.6%) were in the ID group-132 (42.6%) had HIV and 28 (9.0%) had another ID, and 150 (48.4%) were in the NID group. The mean age was 43.64 ± 16.76 years, and 188 (60.6%) were male. There were 285 (91.9%) TBM, 16 (5.2%) tuberculoma/abscess, and 9 (2.9%) myelitis cases. The TBM characteristics in the ID group were younger age (p = 0.003), deep subcortical location of tuberculoma (p = 0.030), lower hemoglobin level (p 
doi_str_mv 10.1186/s12941-023-00615-w
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9a6ef810a3be48a490e7657b71177fe9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A760023514</galeid><doaj_id>oai_doaj_org_article_9a6ef810a3be48a490e7657b71177fe9</doaj_id><sourcerecordid>A760023514</sourcerecordid><originalsourceid>FETCH-LOGICAL-c564t-e7a160cc66c3748b05e9d8bb0b5dcbe10c5b5b2d74fbfee5fe4d89a3481811733</originalsourceid><addsrcrecordid>eNptUstuFDEQHCEQCYEf4IAsceEywZ7xY5YLisIrUiQucLb86Nn1asYO9sxG-z98KL3ZJWQj5ENb3VVldbmq6jWj54x18n1hzYKzmjZtTalkor59Up0yrmRNFWNPH9xPqhelrCltEKeeVyetEoKqhp1Wvz-FMoW4nENZYSFuCDE4MxC3Mtm4CfJu7gpJPXEQp4yjCHmT5kLKtkwwkmm2kN08pBIKCZGEcZxj8tAHF5BBTPQkplg_7ofowyb42QzlAzGENfUWTCYZppzKDbgpbICUafbbl9WzHlHw6lDPqp9fPv-4_FZff_96dXlxXTsh-VSDMkxS56R0reKdpQIWvrOWWuGdBUadsMI2XvHe9gCiB-67hWl5xzrGVNueVVd7XZ_MWt_kMJq81ckEfddIealNRjcG0Asjoe8YNa0F3hm-oKCkUBbNVqqHBWp93GvdzHYEf_DuSPR4EsNKL9NGM8opCktUeHdQyOnXDGXSYygOhsFEQPt103GluOScIvTtI-g6zTmiV4gSDes63rb_UEuDG4TYJ3zY7UT1hZKYjlYwjqjz_6DweBiDSxH_D_tHhGZPcPhvJUN_vySjehdUvQ-qRry-C6q-RdKbh_bcU_4ms_0Ds-PoNA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2852188433</pqid></control><display><type>article</type><title>Distinguishing clinical characteristics of central nervous system tuberculosis in immunodeficient and non-immunodeficient individuals: a 12-year retrospective study</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Saifon, Woraseth ; Karaketklang, Khemajira ; Jitmuang, Anupop</creator><creatorcontrib>Saifon, Woraseth ; Karaketklang, Khemajira ; Jitmuang, Anupop</creatorcontrib><description>Central nervous system tuberculosis (CNS TB) is a severe Mycobacterium tuberculosis (MTB) infection. It is unclear whether a patient's immune status alters the clinical manifestations and treatment outcomes of CNS TB. Between January 2007-December 2018, chart reviews of CNS TB, including tuberculous meningitis (TBM), tuberculoma/abscess, and TB myelitis, were made. Subjects were categorized as immunodeficient (ID) and non-immunodeficient (NID). Of 310 subjects, 160 (51.6%) were in the ID group-132 (42.6%) had HIV and 28 (9.0%) had another ID, and 150 (48.4%) were in the NID group. The mean age was 43.64 ± 16.76 years, and 188 (60.6%) were male. There were 285 (91.9%) TBM, 16 (5.2%) tuberculoma/abscess, and 9 (2.9%) myelitis cases. The TBM characteristics in the ID group were younger age (p = 0.003), deep subcortical location of tuberculoma (p = 0.030), lower hemoglobin level (p &lt; 0.001), and lower peripheral white blood cell count (p &lt; 0.001). Only HIV individuals with TBM had an infection by multidrug-resistant MTB (p = 0.013). TBM mortality was varied by immune status -HIV 22.8%, other ID 29.6%, and NID 14.8% (p &lt; 0.001). Factors significantly associated with unfavorable outcomes in TBM also differed between the HIV and NID groups. TBM is the most significant proportion of CNS TB. Some of the clinical characteristics of TBM, such as age, radiographic findings, hematological derangement, and mortality, including factors associated with unfavorable outcomes, differed between ID and non-ID patients.</description><identifier>ISSN: 1476-0711</identifier><identifier>EISSN: 1476-0711</identifier><identifier>DOI: 10.1186/s12941-023-00615-w</identifier><identifier>PMID: 37550721</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Abscess ; Abscesses ; Acids ; Adult ; Age ; Blood cell count ; Care and treatment ; Central nervous system ; Cerebrospinal fluid ; Clinical outcomes ; Complications and side effects ; Demographic aspects ; Diagnosis ; Female ; Health aspects ; Hemoglobin ; HIV ; HIV Infections - complications ; Human immunodeficiency virus ; Humans ; Immune status ; Immunodeficiency ; Infections ; Leukocytes ; Male ; Meningitis ; Middle Aged ; Mortality ; Multidrug resistance ; Mycobacterium tuberculosis ; Myelitis ; Nervous system ; Patients ; Pulmonary tuberculosis ; Radiography ; Retrospective Studies ; Sample size ; Spinal cord ; Tuberculoma ; Tuberculoma - complications ; Tuberculosis ; Tuberculosis, Central Nervous System - complications ; Tuberculosis, Central Nervous System - diagnosis ; Tuberculosis, Central Nervous System - drug therapy ; Tuberculosis, Meningeal - complications ; Tuberculosis, Meningeal - diagnosis ; Tuberculosis, Meningeal - drug therapy</subject><ispartof>Annals of clinical microbiology and antimicrobials, 2023-08, Vol.22 (1), p.69-69, Article 69</ispartof><rights>2023. BioMed Central Ltd., part of Springer Nature.</rights><rights>COPYRIGHT 2023 BioMed Central Ltd.</rights><rights>2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>BioMed Central Ltd., part of Springer Nature 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c564t-e7a160cc66c3748b05e9d8bb0b5dcbe10c5b5b2d74fbfee5fe4d89a3481811733</citedby><cites>FETCH-LOGICAL-c564t-e7a160cc66c3748b05e9d8bb0b5dcbe10c5b5b2d74fbfee5fe4d89a3481811733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408106/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2852188433?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37550721$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saifon, Woraseth</creatorcontrib><creatorcontrib>Karaketklang, Khemajira</creatorcontrib><creatorcontrib>Jitmuang, Anupop</creatorcontrib><title>Distinguishing clinical characteristics of central nervous system tuberculosis in immunodeficient and non-immunodeficient individuals: a 12-year retrospective study</title><title>Annals of clinical microbiology and antimicrobials</title><addtitle>Ann Clin Microbiol Antimicrob</addtitle><description>Central nervous system tuberculosis (CNS TB) is a severe Mycobacterium tuberculosis (MTB) infection. It is unclear whether a patient's immune status alters the clinical manifestations and treatment outcomes of CNS TB. Between January 2007-December 2018, chart reviews of CNS TB, including tuberculous meningitis (TBM), tuberculoma/abscess, and TB myelitis, were made. Subjects were categorized as immunodeficient (ID) and non-immunodeficient (NID). Of 310 subjects, 160 (51.6%) were in the ID group-132 (42.6%) had HIV and 28 (9.0%) had another ID, and 150 (48.4%) were in the NID group. The mean age was 43.64 ± 16.76 years, and 188 (60.6%) were male. There were 285 (91.9%) TBM, 16 (5.2%) tuberculoma/abscess, and 9 (2.9%) myelitis cases. The TBM characteristics in the ID group were younger age (p = 0.003), deep subcortical location of tuberculoma (p = 0.030), lower hemoglobin level (p &lt; 0.001), and lower peripheral white blood cell count (p &lt; 0.001). Only HIV individuals with TBM had an infection by multidrug-resistant MTB (p = 0.013). TBM mortality was varied by immune status -HIV 22.8%, other ID 29.6%, and NID 14.8% (p &lt; 0.001). Factors significantly associated with unfavorable outcomes in TBM also differed between the HIV and NID groups. TBM is the most significant proportion of CNS TB. Some of the clinical characteristics of TBM, such as age, radiographic findings, hematological derangement, and mortality, including factors associated with unfavorable outcomes, differed between ID and non-ID patients.</description><subject>Abscess</subject><subject>Abscesses</subject><subject>Acids</subject><subject>Adult</subject><subject>Age</subject><subject>Blood cell count</subject><subject>Care and treatment</subject><subject>Central nervous system</subject><subject>Cerebrospinal fluid</subject><subject>Clinical outcomes</subject><subject>Complications and side effects</subject><subject>Demographic aspects</subject><subject>Diagnosis</subject><subject>Female</subject><subject>Health aspects</subject><subject>Hemoglobin</subject><subject>HIV</subject><subject>HIV Infections - complications</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immune status</subject><subject>Immunodeficiency</subject><subject>Infections</subject><subject>Leukocytes</subject><subject>Male</subject><subject>Meningitis</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Multidrug resistance</subject><subject>Mycobacterium tuberculosis</subject><subject>Myelitis</subject><subject>Nervous system</subject><subject>Patients</subject><subject>Pulmonary tuberculosis</subject><subject>Radiography</subject><subject>Retrospective Studies</subject><subject>Sample size</subject><subject>Spinal cord</subject><subject>Tuberculoma</subject><subject>Tuberculoma - complications</subject><subject>Tuberculosis</subject><subject>Tuberculosis, Central Nervous System - complications</subject><subject>Tuberculosis, Central Nervous System - diagnosis</subject><subject>Tuberculosis, Central Nervous System - drug therapy</subject><subject>Tuberculosis, Meningeal - complications</subject><subject>Tuberculosis, Meningeal - diagnosis</subject><subject>Tuberculosis, Meningeal - drug therapy</subject><issn>1476-0711</issn><issn>1476-0711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUstuFDEQHCEQCYEf4IAsceEywZ7xY5YLisIrUiQucLb86Nn1asYO9sxG-z98KL3ZJWQj5ENb3VVldbmq6jWj54x18n1hzYKzmjZtTalkor59Up0yrmRNFWNPH9xPqhelrCltEKeeVyetEoKqhp1Wvz-FMoW4nENZYSFuCDE4MxC3Mtm4CfJu7gpJPXEQp4yjCHmT5kLKtkwwkmm2kN08pBIKCZGEcZxj8tAHF5BBTPQkplg_7ofowyb42QzlAzGENfUWTCYZppzKDbgpbICUafbbl9WzHlHw6lDPqp9fPv-4_FZff_96dXlxXTsh-VSDMkxS56R0reKdpQIWvrOWWuGdBUadsMI2XvHe9gCiB-67hWl5xzrGVNueVVd7XZ_MWt_kMJq81ckEfddIealNRjcG0Asjoe8YNa0F3hm-oKCkUBbNVqqHBWp93GvdzHYEf_DuSPR4EsNKL9NGM8opCktUeHdQyOnXDGXSYygOhsFEQPt103GluOScIvTtI-g6zTmiV4gSDes63rb_UEuDG4TYJ3zY7UT1hZKYjlYwjqjz_6DweBiDSxH_D_tHhGZPcPhvJUN_vySjehdUvQ-qRry-C6q-RdKbh_bcU_4ms_0Ds-PoNA</recordid><startdate>20230807</startdate><enddate>20230807</enddate><creator>Saifon, Woraseth</creator><creator>Karaketklang, Khemajira</creator><creator>Jitmuang, Anupop</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230807</creationdate><title>Distinguishing clinical characteristics of central nervous system tuberculosis in immunodeficient and non-immunodeficient individuals: a 12-year retrospective study</title><author>Saifon, Woraseth ; Karaketklang, Khemajira ; Jitmuang, Anupop</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c564t-e7a160cc66c3748b05e9d8bb0b5dcbe10c5b5b2d74fbfee5fe4d89a3481811733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Abscess</topic><topic>Abscesses</topic><topic>Acids</topic><topic>Adult</topic><topic>Age</topic><topic>Blood cell count</topic><topic>Care and treatment</topic><topic>Central nervous system</topic><topic>Cerebrospinal fluid</topic><topic>Clinical outcomes</topic><topic>Complications and side effects</topic><topic>Demographic aspects</topic><topic>Diagnosis</topic><topic>Female</topic><topic>Health aspects</topic><topic>Hemoglobin</topic><topic>HIV</topic><topic>HIV Infections - complications</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immune status</topic><topic>Immunodeficiency</topic><topic>Infections</topic><topic>Leukocytes</topic><topic>Male</topic><topic>Meningitis</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Multidrug resistance</topic><topic>Mycobacterium tuberculosis</topic><topic>Myelitis</topic><topic>Nervous system</topic><topic>Patients</topic><topic>Pulmonary tuberculosis</topic><topic>Radiography</topic><topic>Retrospective Studies</topic><topic>Sample size</topic><topic>Spinal cord</topic><topic>Tuberculoma</topic><topic>Tuberculoma - complications</topic><topic>Tuberculosis</topic><topic>Tuberculosis, Central Nervous System - complications</topic><topic>Tuberculosis, Central Nervous System - diagnosis</topic><topic>Tuberculosis, Central Nervous System - drug therapy</topic><topic>Tuberculosis, Meningeal - complications</topic><topic>Tuberculosis, Meningeal - diagnosis</topic><topic>Tuberculosis, Meningeal - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saifon, Woraseth</creatorcontrib><creatorcontrib>Karaketklang, Khemajira</creatorcontrib><creatorcontrib>Jitmuang, Anupop</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Proquest Health and Medical Complete</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Annals of clinical microbiology and antimicrobials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saifon, Woraseth</au><au>Karaketklang, Khemajira</au><au>Jitmuang, Anupop</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Distinguishing clinical characteristics of central nervous system tuberculosis in immunodeficient and non-immunodeficient individuals: a 12-year retrospective study</atitle><jtitle>Annals of clinical microbiology and antimicrobials</jtitle><addtitle>Ann Clin Microbiol Antimicrob</addtitle><date>2023-08-07</date><risdate>2023</risdate><volume>22</volume><issue>1</issue><spage>69</spage><epage>69</epage><pages>69-69</pages><artnum>69</artnum><issn>1476-0711</issn><eissn>1476-0711</eissn><abstract>Central nervous system tuberculosis (CNS TB) is a severe Mycobacterium tuberculosis (MTB) infection. It is unclear whether a patient's immune status alters the clinical manifestations and treatment outcomes of CNS TB. Between January 2007-December 2018, chart reviews of CNS TB, including tuberculous meningitis (TBM), tuberculoma/abscess, and TB myelitis, were made. Subjects were categorized as immunodeficient (ID) and non-immunodeficient (NID). Of 310 subjects, 160 (51.6%) were in the ID group-132 (42.6%) had HIV and 28 (9.0%) had another ID, and 150 (48.4%) were in the NID group. The mean age was 43.64 ± 16.76 years, and 188 (60.6%) were male. There were 285 (91.9%) TBM, 16 (5.2%) tuberculoma/abscess, and 9 (2.9%) myelitis cases. The TBM characteristics in the ID group were younger age (p = 0.003), deep subcortical location of tuberculoma (p = 0.030), lower hemoglobin level (p &lt; 0.001), and lower peripheral white blood cell count (p &lt; 0.001). Only HIV individuals with TBM had an infection by multidrug-resistant MTB (p = 0.013). TBM mortality was varied by immune status -HIV 22.8%, other ID 29.6%, and NID 14.8% (p &lt; 0.001). Factors significantly associated with unfavorable outcomes in TBM also differed between the HIV and NID groups. TBM is the most significant proportion of CNS TB. Some of the clinical characteristics of TBM, such as age, radiographic findings, hematological derangement, and mortality, including factors associated with unfavorable outcomes, differed between ID and non-ID patients.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>37550721</pmid><doi>10.1186/s12941-023-00615-w</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1476-0711
ispartof Annals of clinical microbiology and antimicrobials, 2023-08, Vol.22 (1), p.69-69, Article 69
issn 1476-0711
1476-0711
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_9a6ef810a3be48a490e7657b71177fe9
source Publicly Available Content Database; PubMed Central
subjects Abscess
Abscesses
Acids
Adult
Age
Blood cell count
Care and treatment
Central nervous system
Cerebrospinal fluid
Clinical outcomes
Complications and side effects
Demographic aspects
Diagnosis
Female
Health aspects
Hemoglobin
HIV
HIV Infections - complications
Human immunodeficiency virus
Humans
Immune status
Immunodeficiency
Infections
Leukocytes
Male
Meningitis
Middle Aged
Mortality
Multidrug resistance
Mycobacterium tuberculosis
Myelitis
Nervous system
Patients
Pulmonary tuberculosis
Radiography
Retrospective Studies
Sample size
Spinal cord
Tuberculoma
Tuberculoma - complications
Tuberculosis
Tuberculosis, Central Nervous System - complications
Tuberculosis, Central Nervous System - diagnosis
Tuberculosis, Central Nervous System - drug therapy
Tuberculosis, Meningeal - complications
Tuberculosis, Meningeal - diagnosis
Tuberculosis, Meningeal - drug therapy
title Distinguishing clinical characteristics of central nervous system tuberculosis in immunodeficient and non-immunodeficient individuals: a 12-year retrospective study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T17%3A19%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Distinguishing%20clinical%20characteristics%20of%20central%20nervous%20system%20tuberculosis%20in%20immunodeficient%20and%20non-immunodeficient%20individuals:%20a%2012-year%20retrospective%20study&rft.jtitle=Annals%20of%20clinical%20microbiology%20and%20antimicrobials&rft.au=Saifon,%20Woraseth&rft.date=2023-08-07&rft.volume=22&rft.issue=1&rft.spage=69&rft.epage=69&rft.pages=69-69&rft.artnum=69&rft.issn=1476-0711&rft.eissn=1476-0711&rft_id=info:doi/10.1186/s12941-023-00615-w&rft_dat=%3Cgale_doaj_%3EA760023514%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c564t-e7a160cc66c3748b05e9d8bb0b5dcbe10c5b5b2d74fbfee5fe4d89a3481811733%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2852188433&rft_id=info:pmid/37550721&rft_galeid=A760023514&rfr_iscdi=true